Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
1. Sana Biotechnology shows a significant surge with a 162% increase in stock price. 2. Mesoblast's RSI indicates overbought status following FDA approval, yet its stock fell 4%. 3. Both stocks are highlighted as overbought, which may indicate potential corrections.